Cannabis was associated with fewer than one percent of all substance use-related cardiovascular deaths, investigators determined.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Patients presenting with severe baseline anxiety were most likely to experience a clinically significant improvement in anxiety symptoms at 12 months.
Just under half (48 percent) of respondents acknowledged having experience with cannabis.
“This study suggests that lifetime exposure to cannabis has few persistent effects on mental health and other psychosocial outcomes,” researchers reported.
Chronic pain patients in the survey reported “greater satisfaction” with cannabis and said that it was “more effective” than their prior therapies.
Previous studies have demonstrated that the co-administration of cannabinoids augments the pain-relieving effects of opioids, even when administered at subtherapeutic doses.
Forty-seven percent of respondents reported having authorized cannabis-based therapies to their pediatric patients.
Investigators concluded, “To our knowledge, this is the first longitudinal cohort study … to report an absence of a relationship between cannabis use and risk of AF.”